Clinical Trials Directory

Trials / Unknown

UnknownNCT06300346

Comparison Between Drugs for Control of Emetic Attacks During Caesarean Delivery

Comparison Between Propofol, Ondansetron and Pregabalin for Control of Emetic Attacks During Caesarean Delivery With Spinal Anesthesia: Randomized Clinical Trial

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
90 (estimated)
Sponsor
Sohag University · Academic / Other
Sex
Female
Age
21 Years – 40 Years
Healthy volunteers
Accepted

Summary

Single shot spinal anesthesia is widely used for most surgical operations especially in obstetric such as hysterectomy, tubal ligation after vaginal delivery, cesarean and curettage etc.; however, in general, cesarean is considered as the most common indication for spinal anesthesia in pregnant women Intra-operative nausea and vomiting/retching (NVR) may be experienced by 20% to 80% of women undergoing cesarean section (CS) with subarachnoid anesthesia (SA) in the absence of antiemetic prophylaxis. Different treatment options are available to reduce post operative nausea and vomiting (PONV) so we will make a Comparison between Propofol, Ondansetron and Pregabalin for Control of Emetic Attacks during Caesarean Delivery with Spinal Anesthesia

Conditions

Interventions

TypeNameDescription
DRUGPropofolOndansetron

Timeline

Start date
2024-03-01
Primary completion
2024-08-18
Completion
2024-08-18
First posted
2024-03-08
Last updated
2024-03-08

Source: ClinicalTrials.gov record NCT06300346. Inclusion in this directory is not an endorsement.

Comparison Between Drugs for Control of Emetic Attacks During Caesarean Delivery (NCT06300346) · Clinical Trials Directory